Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00194194 · ClinicalTrials.gov registry record · Phase 2

Healthetech, Inc. SMART Study

A Phase 2 study of Moderate Behavior Management and Intensive Behavior Management, sponsored by Temple University.

Completed
Registry status
Phase 2
Development phase
56
Enrollment target
1
Study location

NCT00194194 is a Phase 2 study of Moderate Behavior Management and Intensive Behavior Management that has completed, run by Temple University. The registered enrollment target is 56 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00194194, a Phase 2 study of Moderate Behavior Management and Intensive Behavior Management, has completed, sponsored by Temple University.

COMPLETED
Registry status
Phase 2
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This study is designed to gain experience with the HealtheTech measurement system (BalanceLog) in the context of a clinical trial and to develop the related treatment protocols. In this study the aim is to evaluate two interventions, one moderate and the other intensive behavioral management. The development and evaluation of a HealtheTech protocol across these two treatment settings will provide useful data about implementation (e.g., technical issues, clinical issues, participant satisfaction) and outcomes (weight loss, retention). These data can provide empirical and clinical support for practice guidelines.

Interventions

  • BEHAVIORAL moderate
  • DEVICE Resting Metablic Rate measurements

Study Locations (1)

Pennsylvania

  • Temple University- Center for Obesity Research and Education - Philadelphia

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2004-08
Est. Completion 2007-03
Phase Phase 2

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT00194194

The ClinicalTrials.gov registry entry for NCT00194194 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Moderate Behavior Management appearing as the primary indexed condition, and to 2 interventions - of which moderate is the first listed.

NCT00194194 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00194194 about?

NCT00194194 is a clinical study titled "Healthetech, Inc. SMART Study". This study is designed to gain experience with the HealtheTech measurement system (BalanceLog) in the context of a clinical trial and to develop the related treatment protocols. In this study the aim is to evaluate two interventions, one moderate and the other intensive behavioral management. The de...

What is the current status of trial NCT00194194?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2004-08. Estimated completion is 2007-03.

What conditions does trial NCT00194194 study?

This clinical trial studies the following conditions: Moderate Behavior Management, Intensive Behavior Management.

What interventions are being tested in trial NCT00194194?

The interventions under investigation include: moderate (BEHAVIORAL), Resting Metablic Rate measurements (DEVICE).

Who is sponsoring clinical trial NCT00194194?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00194194 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.